Clinical Trial Update: Fenofibrate and Propranolol in Burn Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating fenofibrate and propranolol in burn patients was terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Propranolol (propranolol)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Burn | Phase 2, Phase 3 | Status: TERMINATED